Coty paid $12B for P&G's beauty brands — then wrote off billions and sold the crown jewels

Coty was a century-old fragrance and cosmetics company, best known for brands like Calvin Klein, Marc Jacobs, and philosophy. In 2015 it struck a deal to acquire 41 beauty brands from Procter & Gamble — including Clairol, CoverGirl, Max Factor, Wella, and the licenses for Gucci, Hugo Boss, and Lacoste fragrances — in a transaction valued at roughly $12 billion. The deal was structured as a Reverse Morris Trust and made Coty the third-largest global cosmetics company overnight.

The acquisition was funded almost entirely with debt. Coty's balance sheet ballooned, and the company immediately faced severe integration challenges. The P&G brands had been run inside a massive consumer-goods machine with completely different systems, supply chains, and corporate culture. Coty's quarterly profit fell sharply, and by August 2017 the company was reporting losses. Its stock price, which had traded around $30 before the deal, slid below $10 by 2019.

In 2018, Coty was forced to undertake an $8 billion jumbo refinancing to manage its debt load. The company attempted a turnaround under new leadership, but the damage was already done. In December 2020, Coty sold Wella, Clairol, OPI, and ghd to private equity firm KKR for $2.5 billion in cash — a fraction of what it had paid for the broader portfolio just four years earlier. Coty retained a 40% stake, which it further reduced in 2021.

The sale effectively ended Coty's experiment as a mega-cosmetics house. The company refocused on its core fragrance and prestige business, but the P&G acquisition had consumed years of management attention, destroyed billions in shareholder value, and left the company permanently smaller than it had aimed to be.

Borrowed $12B to buy 41 declining brands, then sold Wella and Clairol to KKR for $2.5B, a fraction of the price, after integration failed.

The $12B deal was funded almost entirely with debt, leaving Coty with no financial cushion when integration proved harder and slower than expected

Coty underestimated the complexity of absorbing 41 brands from a vastly larger company with different systems, supply chains, and management practices

The P&G brands were legacy assets with declining market share — Coty bought size, not growth, and paid a premium for brands that were already losing ground

Management was consumed by integration for years, during which the core fragrance business — Coty's original strength — was neglected and lost momentum

Buying a portfolio of declining brands with borrowed money does not create growth — it turns a healthy company into a leveraged caretaker of someone else's cast-offs.

Coty sold Wella, Clairol, OPI, and ghd to KKR for $2.5B in 2020, then reduced its remaining stake. The company refocused on prestige fragrances and returned to its pre-deal scope. The case became a textbook example of acquisition indigestion and the danger of taking on massive debt to buy size without strategic fit.